Low-dose Lenalidomide Maintenance after Stem Cell Transplantation for High-risk Leukemia or Syndrome
A new study conducted by researchers at various institutions, including the University of Texas MD Anderson Cancer Center and the Center for International Blood and Marrow Transplant Research, has found